Endocrine Society member Joseph T. Bass, MD, PhD, has been elected to the American Academy of Arts & Sciences (AAAS). Bass is the Charles F. Kettering Professor of Medicine at Northwestern University Feinberg School of Medicine in Chicago, Ill. As a world leader in circadian biology and endocrinology, his creativity and insights as an endocrinologist...
Almost three years ago, Kotaro Sasaki, MD, PhD, was lauded as one of the Endocrine Society’s Early Investigator Award winners. Now he discusses his research that involves building a human adrenal gland from stem cells, the importance for scientists to attend ENDO, and why the process of publishing research can often prove challenging. What if...
People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than those on a low-fat diet, according to a small study published in the Journal of the Endocrine Society. Type 2 diabetes is a disease where the beta cells in the pancreas cannot secrete enough insulin...
Spring in the northern hemisphere is a time of exploration, growth, and transition. That’s why I’m excited this month to highlight our Society programs that help rising clinicians and researchers explore, grow, and transition to careers in endocrinology. One of our newer programs is the Medical School Engagement Program (MSEP), which in April will welcome...
Constant vigilance is required for both the patient and the clinicians when treating people with congenital adrenal hyperplasia. Early screening, diligent monitoring, and a holistic approach can ensure that complications are kept at bay and the patients can maintain a high quality of life. In the quiet exam rooms of specialized endocrine clinics, a high-stakes...
Four Studies that Can Improve Patient Outcomes Since April is Adrenal Disease Awareness Month, Endocrine News is highlighting recent studies that shed light on important advances and insights in the field. These studies, all published in Endocrine Society journals, show how improved diagnostic accuracy, postoperative management, and a better understanding of rare adrenal pathologies offer...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Amgen Announces Positive Top-Line Phase 3 Results for TED Treatment On April 6, Amgen announced positive topline results from a Phase 3 trial of TEPEZZA (teprotumumab-trbw) administered by subcutaneous injection via an on-body injector (OBI) in participants with moderate-to-severe active thyroid...
Researchers have identified fasting hyperinsulinemia as a primary, yet often overlooked, driver of metabolic dysfunction-associated steatotic liver disease (MASLD). A new review published in Hepatology suggests that elevated insulin levels are not merely a symptom of metabolic syndrome but a direct contributor to liver fibrosis and a potent predictor of major adverse liver and cardiovascular...
Spring in the northern hemisphere is a time of exploration, growth, and transition. That’s why I’m excited this month to highlight our Society programs that help rising clinicians and researchers explore, grow, and transition to careers in endocrinology. One of our newer programs is the Medical School Engagement Program (MSEP), which in April will welcome...
Four Studies that Can Improve Patient Outcomes Since April is Adrenal Disease Awareness Month, Endocrine News is highlighting recent studies that shed light on important advances and insights in the field. These studies, all published in Endocrine Society journals, show how improved diagnostic accuracy, postoperative management, and a better understanding of rare adrenal pathologies offer...
